SomaLogic Appoints Jason Cleveland, Ph.D. as Chief Technology Officer
(MENAFN- GlobeNewsWire - Nasdaq) BOULDER, Colo., Jan. 08, 2021 (GLOBE NEWSWIRE) -- SomaLogic Inc., a global leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics, today announced the appointment of Jason Cleveland, Ph.D. as the company's chief technology officer. In this role, Dr. Cleveland will drive technological innovations that will bring the SomaScan® proteomics platform to patients around the world.
'Jason has built a career on his passion for building scientific instruments,' said Melody Harris, president and chief operating officer of SomaLogic. 'His unique background is the balance between science, engineering and business that we need to bring proteomics to a much wider customer base.'
Dr. Cleveland has more than 25 years of experience as a technology innovator in the area of scientific instruments. He began at SomaLogic as a consultant in 2015 and later became a principal research fellow in 2018. His work at SomaLogic focused on both near-term improvements to the SomaScan platform as well as technologies to move towards patient-focused proteomics.
Prior to joining SomaLogic, Dr. Cleveland was the cofounder, chairman and later, chief executive officer of Asylum Research in Santa Barbara, California, a manufacturer of atomic force microscopes founded in 1999. As a hands-on CEO, he was heavily involved in the design of the Cypher AFM, which is still the quietest, fastest and most stable research atomic force microscope in the world with an installed base of more than 1,000 instruments. He began his career at Digital Instruments, which was the largest atomic force microscope company at the time.
Dr. Cleveland has a Ph.D. in physics from the University of California, Santa Barbara and bachelor's degrees in math and physics from the University of Minnesota. He is a Fellow of the American Physical Society. He is also an author on 40 scientific publications and an inventor on 47 patents.
###
About SomaLogic
SomaLogic seeks to deliver precise, meaningful, and actionable health-management information that empowers individuals worldwide to continuously optimize their personal health and wellness throughout their lives. This essential information, to be provided through a global network of partners and users, is derived from SomaLogic's precise, proprietary, and personalized measurement of important changes in an individual's proteins over time. For more information, visit [...] and follow @somalogic on Twitter .

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- NOVA Collective Invest Showcases Intelligent Trading System7.0 Iterations Led By Brady Rodriguez
- VCUK Launches New Private Equity And Venture Capital Initiative With A Focus On Europe
- From Zero To Crypto Hero In 25 Minutes: Changelly Introduces A Free Gamified Crash Course
- Blackrock Becomes The Second-Largest Shareholder Of Freedom Holding Corp.
- Cartesian Launches First Outsourced Middle-Back-Office Offering For Digital Asset Funds
- Ethereum Based Meme Coin Pepeto Presale Past $6.7 Million As Exchange Demo Launches
Comments
No comment